How infection present at time of surgery (PATOS) data impacts your surgical site infection (SSI) standardized infection ratios (SIR), with focus on the complex 30-day SSI SIR model.


Journal

American journal of infection control
ISSN: 1527-3296
Titre abrégé: Am J Infect Control
Pays: United States
ID NLM: 8004854

Informations de publication

Date de publication:
11 2021
Historique:
received: 07 05 2021
accepted: 11 05 2021
entrez: 25 10 2021
pubmed: 26 10 2021
medline: 29 10 2021
Statut: ppublish

Résumé

This case study is part of a series centered on the Centers for Disease Control and Prevention's National Healthcare Safety Network's (NHSN) health care-associated infection (HAI) surveillance definitions. This is the first analytic case study published in AJIC since the CDC/ NHSN updated its HAI risk adjustment models and rebaselined the standardized infection ratios (SIRs) in 2015. This case describes a scenario that Infection Preventionists (IPs) have encountered during their analysis of surgical site infection (SSI) surveillance data. The case study is intended to illustrate how specific models can impact the SIR results by highlighting differences in the criteria for NHSN's older and newer risk models: the original versions and the updated models introduced in 2015. Understanding these differences provides insight into how SSI SIR calculations differ between the older and newer NHSN baseline models. NHSN plans to produce another set of HAI risk adjustment models in the future, using newer HAI incidence and risk factor data. While the timetable for these changes remains to be determined, the statistical methods used to produce future models and SIR calculations will continue the precedents that NHSN has established. An online survey link is provided where participants may confidentially answer questions related to the case study and receive immediate feedback in the form of correct answers, explanations, rationales, and summary of teaching points. Details of the case study, answers, and explanations have been reviewed and approved by NHSN staff. We hope that participants take advantage of this educational offering and thereby gain a greater understanding of the NHSN's HAI data analysis. There are 2 baselines available for SSI standardized infection ration (SIRs) in the National Healthcare Safety Network (NHSN); one based on the 2006-2008 national aggregate data and another based on the 2015 data. Each of the 2 baselines has a different set of inclusion criteria for the SSI data, which impact the calculation of the SIR. In this case study, we focused on the impact of the inclusion of PATOS in the calculation of the 2006-2008 baseline SSI SIR and the exclusion of PATOS from the calculation of the 2015 baseline SSI SIR. In the 2006-2008 baseline SSI SIRs, PATOS events and the procedures to which they are linked are included in the calculation of the SSI SIR whereas in the 2015 baseline SSI SIRs, PATOS events and the procedures to which they are linked are excluded from the calculation of the SSI SIR. Meaning, if we control for all other inclusion criteria other than PATOS data for both baselines, we will notice differences in the number of observed events as well as the number of predicted infections for the 2 baselines. For details of the 2015 baseline and risk adjustment calculation, please review the NHSN Guide to the SIR referenced below. For details of the 2006-2008 baseline4 and risk adjustment, please see the SHEA paper "Improving Risk-Adjusted Measures of Surgical Site Infection for the National Healthcare Safety Network" by author Yi Mu.

Identifiants

pubmed: 34689884
pii: S0196-6553(21)00343-6
doi: 10.1016/j.ajic.2021.05.002
pmc: PMC9641641
mid: NIHMS1842220
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1423-1426

Subventions

Organisme : Intramural CDC HHS
ID : CC999999
Pays : United States

Informations de copyright

Copyright © 2021 Association for Professionals in Infection Control and Epidemiology, Inc. All rights reserved.

Références

Am J Infect Control. 2010 Jun;38(5):416-8
pubmed: 20583335
Infect Control Hosp Epidemiol. 2011 Oct;32(10):970-86
pubmed: 21931247

Auteurs

Rebecca Konnor (R)

CACI, Subcontractor to Leidos | Contractor for the National Healthcare Safety Network (NHSN), NCEZID, Division of Healthcare Quality Promotion (DHQP), Centers for Disease Control and Prevention, Atlanta, GA. Electronic address: Yck1@cdc.gov.

Victoria Russo (V)

CACI, Subcontractor to Leidos | Contractor for the National Healthcare Safety Network (NHSN), NCEZID, Division of Healthcare Quality Promotion (DHQP), Centers for Disease Control and Prevention, Atlanta, GA.

Denise Leaptrot (D)

CACI, Subcontractor to Leidos | Contractor for the National Healthcare Safety Network (NHSN), NCEZID, Division of Healthcare Quality Promotion (DHQP), Centers for Disease Control and Prevention, Atlanta, GA.

Katherine Allen-Bridson (K)

Surveillance Branch, NCEZID, Division of Healthcare Quality Promotion (DHQP), Centers for Disease Control and Prevention, Atlanta, GA.

Margaret A Dudeck (MA)

Surveillance Branch, NCEZID, Division of Healthcare Quality Promotion (DHQP), Centers for Disease Control and Prevention, Atlanta, GA.

Joan N Hebden (JN)

Independent Infection Prevention Consultant, Baltimore, MD.

Marc-Oliver Wright (MO)

Clinical Science Liaison, Central Region, IL.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH